Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
9.39
+0.43 (4.80%)
At close: Mar 9, 2026, 4:00 PM EDT
9.35
-0.04 (-0.43%)
After-hours: Mar 9, 2026, 7:56 PM EDT
Kura Oncology Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 149.1 | 224.46 | 37.32 | 51.8 | 90.67 | Upgrade
|
| Short-Term Investments | 518.14 | 502.93 | 386.64 | 386.18 | 427.29 | Upgrade
|
| Cash & Short-Term Investments | 667.24 | 727.4 | 423.96 | 437.99 | 517.96 | Upgrade
|
| Cash Growth | -8.27% | 71.57% | -3.20% | -15.44% | -18.21% | Upgrade
|
| Accounts Receivable | 8.8 | 2.06 | - | - | - | Upgrade
|
| Other Receivables | 3.8 | 3.3 | 1.1 | 0.9 | 1.4 | Upgrade
|
| Receivables | 12.6 | 5.36 | 1.1 | 0.9 | 1.4 | Upgrade
|
| Inventory | 0.41 | - | - | - | - | Upgrade
|
| Prepaid Expenses | 28.41 | 12.07 | 7.42 | 7.54 | 2.93 | Upgrade
|
| Total Current Assets | 708.66 | 744.83 | 432.48 | 446.43 | 522.29 | Upgrade
|
| Property, Plant & Equipment | 15.16 | 7.49 | 8.85 | 6.38 | 8.25 | Upgrade
|
| Other Long-Term Assets | 14.54 | 7.85 | 7.6 | 3.5 | 3.52 | Upgrade
|
| Total Assets | 738.36 | 760.16 | 448.94 | 456.31 | 534.05 | Upgrade
|
| Accounts Payable | 5.02 | 1.47 | 2.3 | 1.53 | 3.24 | Upgrade
|
| Accrued Expenses | 61.08 | 46.42 | 31.46 | 20.21 | 16.96 | Upgrade
|
| Current Portion of Long-Term Debt | - | 2.61 | - | - | - | Upgrade
|
| Current Portion of Leases | 1.28 | 1.88 | 1.51 | 2.32 | 2.26 | Upgrade
|
| Current Income Taxes Payable | 0.24 | 2.06 | - | - | - | Upgrade
|
| Current Unearned Revenue | 48.98 | 24.27 | - | - | - | Upgrade
|
| Other Current Liabilities | 0.38 | - | - | - | - | Upgrade
|
| Total Current Liabilities | 116.97 | 78.71 | 35.26 | 24.06 | 22.46 | Upgrade
|
| Long-Term Debt | 9.71 | 6.92 | 9.33 | 9.16 | - | Upgrade
|
| Long-Term Leases | 9.47 | 5.19 | 6.36 | 2.55 | 4.61 | Upgrade
|
| Long-Term Unearned Revenue | 424.91 | 253.91 | - | - | - | Upgrade
|
| Other Long-Term Liabilities | 3.17 | 1.8 | 0.71 | 0.27 | 0.38 | Upgrade
|
| Total Liabilities | 564.23 | 346.52 | 51.66 | 36.03 | 27.44 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 1,347 | 1,308 | 1,120 | 997.11 | 941.36 | Upgrade
|
| Retained Earnings | -1,174 | -895.42 | -721.44 | -568.81 | -432.97 | Upgrade
|
| Comprehensive Income & Other | 1.02 | 0.76 | -1.27 | -8.03 | -1.79 | Upgrade
|
| Shareholders' Equity | 174.14 | 413.64 | 397.27 | 420.28 | 506.61 | Upgrade
|
| Total Liabilities & Equity | 738.36 | 760.16 | 448.94 | 456.31 | 534.05 | Upgrade
|
| Total Debt | 20.46 | 16.59 | 17.2 | 14.02 | 6.88 | Upgrade
|
| Net Cash (Debt) | 646.78 | 710.8 | 406.76 | 423.96 | 511.09 | Upgrade
|
| Net Cash Growth | -9.01% | 74.75% | -4.06% | -17.05% | -17.35% | Upgrade
|
| Net Cash Per Share | 7.38 | 8.25 | 5.55 | 6.33 | 7.70 | Upgrade
|
| Filing Date Shares Outstanding | 88.33 | 80.75 | 76.14 | 68.44 | 66.61 | Upgrade
|
| Total Common Shares Outstanding | 87.86 | 78.23 | 74.35 | 68.31 | 66.57 | Upgrade
|
| Working Capital | 591.69 | 666.12 | 397.22 | 422.37 | 499.83 | Upgrade
|
| Book Value Per Share | 1.98 | 5.29 | 5.34 | 6.15 | 7.61 | Upgrade
|
| Tangible Book Value | 174.14 | 413.64 | 397.27 | 420.28 | 506.61 | Upgrade
|
| Tangible Book Value Per Share | 1.98 | 5.29 | 5.34 | 6.15 | 7.61 | Upgrade
|
| Machinery | 3.84 | 3.21 | 2.77 | 2.6 | 1.99 | Upgrade
|
| Leasehold Improvements | 6.92 | 1.74 | 1.54 | 1.54 | 1.53 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.